Dendritic Cell Depletion in Burn Patients Is Regulated by MafB Expression
暂无分享,去创建一个
R. Gamelli | M. Halerz | P. Conrad | Li‐Ke He | A. Szilagyi | R. Shankar | K. Williams | K. Muthumalaiappan | Andrea Szilagyi | Kuzhali Muthumalaiappan
[1] R. Gamelli,et al. High MafB expression following burn augments monocyte commitment and inhibits DC differentiation in hemopoietic progenitors , 2012, Journal of leukocyte biology.
[2] R. Steinman,et al. Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas , 2010, Cell.
[3] Silvano Sozzani,et al. Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.
[4] Markus G. Manz,et al. Development of Monocytes, Macrophages, and Dendritic Cells , 2010, Science.
[5] C. Bieglmayer,et al. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation. , 2009, Blood.
[6] R. Pirracchio,et al. Monocytic HLA‐DR expression in intensive care patients: Interest for prognosis and secondary infection prediction * , 2009, Critical care medicine.
[7] K. Bencardino,et al. Flow cytometric detection of circulating dendritic cells in healthy subjects. , 2009, European journal of histochemistry : EJH.
[8] C. Meisel,et al. Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis , 2009, Critical care.
[9] A. Accardo-Palumbo,et al. Circulating dendritic cells following burn. , 2009, Burns : journal of the International Society for Burn Injuries.
[10] Yan Yu,et al. Low HLA-DR expression on CD14+ monocytes of burn victims with sepsis, and the effect of carbachol in vitro. , 2008, Burns : journal of the International Society for Burn Injuries.
[11] S. Naik. Demystifying the development of dendritic cell subtypes, a little , 2008, Immunology and cell biology.
[12] R. Cox,et al. Prophylactic Treatment with Fms-Like Tyrosine Kinase-3 Ligand after Burn Injury Enhances Global Immune Responses to Infection1 , 2008, The Journal of Immunology.
[13] R. Gamelli,et al. Perturbed Bone Marrow Monocyte Development Following Burn Injury and Sepsis Promote Hyporesponsive Monocytes , 2008, Journal of burn care & research : official publication of the American Burn Association.
[14] H. Hammad,et al. From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 22, 2013. For personal use only. , 2005 .
[15] A. Ayala,et al. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock , 2007, Critical care medicine.
[16] Yong‐jun Liu,et al. Development of dendritic-cell lineages. , 2007, Immunity.
[17] Yong-ming Yao,et al. [Clinical significance of changes in quantitative expression of human leukocyte antigen DR in severely burned patients]. , 2007, Zhonghua wai ke za zhi [Chinese journal of surgery].
[18] N. Voirin,et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock , 2006, Intensive Care Medicine.
[19] Ana Cumano,et al. A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells , 2006, Science.
[20] S. Kunkel,et al. Reversal of long-term sepsis-induced immunosuppression by dendritic cells. , 2005, Blood.
[21] C. Miller‐Graziano,et al. Failure of Monocytes of Trauma Patients to Convert to Immature Dendritic Cells is Related to Preferential Macrophage-Colony-Stimulating Factor-Driven Macrophage Differentiation1 , 2003, The Journal of Immunology.
[22] Yong‐jun Liu,et al. Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.
[23] C. Coopersmith,et al. Depletion of Dendritic Cells, But Not Macrophages, in Patients with Sepsis , 2002, The Journal of Immunology.
[24] C. Arias,et al. Origin and differentiation of dendritic cells. , 2001, Trends in immunology.
[25] L Meyer,et al. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. , 2001, Blood.
[26] Y. Liu,et al. Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity , 2001, Cell.
[27] V. Soumelis,et al. Dendritic cell lineage, plasticity and cross-regulation , 2001, Nature Immunology.
[28] S. Ikehara,et al. Differential Regulation of Human Blood Dendritic Cell Subsets by IFNs1 , 2001, The Journal of Immunology.
[29] T. Graf,et al. MafB is an inducer of monocytic differentiation , 2000, The EMBO journal.
[30] T. Ito,et al. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. , 1999, Journal of immunology.
[31] R. Thomas,et al. Proliferation in monocyte-derived dendritic cell cultures is caused by progenitor cells capable of myeloid differentiation. , 1998, Blood.
[32] K. Palucka,et al. Dendritic cells as the terminal stage of monocyte differentiation. , 1998, Journal of immunology.
[33] A. Mackensen,et al. In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell type. , 1996, Blood.
[34] R. Steinman,et al. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. , 1996, Journal of immunological methods.
[35] R. Steinman,et al. Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.
[36] F. Sallusto,et al. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.
[37] R. Steinman,et al. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[38] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[39] G. Schuler,et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. , 1997, Advances in experimental medicine and biology.